Difference in Markers of Microbial Translocation and Cell Apoptosis in HIV Monoinfected and HIV/HCV Coinfected Patients

Abad-Fernandez, M., Vallejo, A., Hernandez-Novoa, B., Diaz, L., Gutierrez, C., Madrid, N., Angeles Munoz, M., Moreno, S. (2013). Correlation between different methods to measure microbial translocation and its association with immune activation in long-term supressed HIV-1 infected individuals. J. Acquir. Immune Defic. Syndr., 64, 149–153.10.1097/QAI.0b013e31829a2f1224047967Search in Google Scholar

Albillos, A., de la Hera, A., Gonzalez, M., Moya, J.-L., Calleja, J.-L., Monserrat, J., Riuz-del-Arbol, L., Alvarez-Mon, M. (2003). Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology, 37 (1), 208–217.10.1053/jhep.2003.5003812500206Search in Google Scholar

Balagopal, A., Phil, F. H., Astemborski, J., Block, T. M., Mehta, A., Long, R., Kirk, G. D., Mehta, S. H., Cox, A. L., Thomas, D. L., Ray, S. C. (2008). Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. Gastroenterology, 135 (1), 226–233.10.1053/j.gastro.2008.03.022264490318457674Search in Google Scholar

Balagopal, A., Gama, L., Franco, V., Russell, J. N., Quinn, J., Higgins, Y., Smeaton, L. M., Clements, J. E., Thomas, D. L., Gupta, A. (2012). Detection of microbial translocation in HIV and SIV infection using the Limulus amebocyte lysate assay is masked by serum and plasma. PLoS ONE, 7 (8), 1–8.10.1371/journal.pone.0041258340985222870212Search in Google Scholar

Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., Blazar, B. R., Rodriguez, B., Teixeira-Johnson, L., Landay, A., Martin, J. N., Hecht, F. M., Picker, L. J., Lederman, M. M., Deeks, S. G., Douek, D. C. (2006). Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nature Med., 12, 1365–1371.10.1038/nm151117115046Search in Google Scholar

Caradonna, L., Mastronardi, M. L., Magrone, T., Cozzolongo, R., Cuppone, R., Manghisi, O. G., Caccavo, D., Pellegrino, N. M., Amoroso, A., Jirillo, E., Amati, L. (2002). Biological and clinical significance of entotoxemia in the course of hepatitis C virus infection. Curr. Pharmaceut. Des., 8, 995–1005.10.2174/138161202460698311945146Search in Google Scholar

Chan, C. C., Hwang, S. J., Lee, F. Y., Wang, S. S., Chang, F. Y., Li, C. P., Chu, C. J., Lu, R. H., Lee, S. D. (1997). Prognostic value of plasma endotoxin levels in patients with cirrhosis. Scand. J. Gastroenterol., 32 (9), 942–945.10.3109/003655297090112069299675Search in Google Scholar

Crane, M., Iser, D., Lewin, S. R. (2012). Human immunodeficiency virus infection and the liver. World J. Hepatol., 4 (3), 91–98.10.4254/wjh.v4.i3.91332149522489261Search in Google Scholar

Dinh, D. M., Volpe, G. E., Duffalo, C., Bhalchandra, S., Tai, A. K., Kane, A. V., Wanke, C. A., Ward, H. D. (2015). Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection. J. Infect. Dis., 211, 19–27.10.1093/infdis/jiu409432631625057045Search in Google Scholar

Epeldegui, M., Magpantay, L., Guo, Y., Halec, G., Cumberland, W. G., Yen, P. K., Macatangay, B., Margolick, J. B., Fositch, A. F., Wolinsky, S., Martinez-Maza, O., Hussain, S. K. (2018). A prospective study of serum microbial translocation biomarkers and risk of AIDS- related non- Hodgkin lymphoma. AIDS, 32 (7), 945–954.10.1097/QAD.0000000000001771586910929424776Search in Google Scholar

Epple, H.-J., Schneider, T., Troeger, H., Kunkel, D., Allers, K., Moos, V., Amasheh, M., Loddenkemper, C., Fromm, M., Zeitz, M., Schulzke, J.-D. (2009). Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV- infected patients. Gut, 58, 220–227.10.1136/gut.2008.15042518936106Search in Google Scholar

French, A., Evans, C. T., Agniel, D. M., Cohen, M. H., Peters, M., Landay, A. L., Desai, S. N. (2013). Microbial translocation and liver disease progression in women coinfected with HIV and hepatitis C virus. J. Infect. Dis., 208, 679–689.10.1093/infdis/jit225371990723687224Search in Google Scholar

Hansjee, N., Kaufmann, G. R., Strub, C., Weber, R., Battegay, M., Erb, P. (2004). Persistent apoptosis in HIV-1-infected individuals receiving potent antiretroviral therapy is associated with poor recovery of CD4 T lymphocytes. J. Acquir. Immune Defic. Syndr., 36, 671–677.10.1097/00126334-200406010-0000315167285Search in Google Scholar

Hatano, H. (2013). Immune activation and HIV persistence: Considerations for novel therapeutic interventions. AIDS, 8 (3), 211–216.10.1097/COH.0b013e32835f9788404148823454864Search in Google Scholar

Jiang, W., Lederman, M. M., Hunt, P., Sieg, S. F., Haley, K., Rodriguez, B., Landay, A., Martin, J., Sinclair, E., Asher, A. I., Deeks, S. G., Douek, D. C., Brenchley, J. M. (2009). Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J. Infect. Dis., 199 (8), 1177–1185.10.1086/597476272862219265479Search in Google Scholar

Jirillo, E., Amati, L., Caradonna, L., Greco, B., Cozzolongo, R., Cuppone, R., Piazzolla, G., Caccavo, D., Antonaci, S., Manghisi, O. G. (1998). Soluble (s) CD14 and plasmatic lipopolysaccharides (LPS) in patients with chronic hepatitis C before and after treatment with interferon (IFN)-α. Immunopharmacol. Immunotoxicol., 20 (1), 1–14.10.3109/089239798090348059543696Search in Google Scholar

Kronenberger, B., von Wagner, M., Herrmann, E., Mihm, U., Piiper, A., Sarrazin, C., Zeuzem, S. (2005). Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C. J. Viral Hepat.,12, 307–314.10.1111/j.1365-2893.2005.00594.x15850472Search in Google Scholar

Lopez-Cortes, L. F., Trujillo-Rodriguez, M., Baez-Palomo, A., Benmarzouk-Hidalgo, O. J., Dominguez-Molina, B., Milanes-Guisado, Y., Espinosa, N., Viciana, P., Gutierrez-Valencia, A. (2018). Eradication of hepatitis C virus (HCV) reduces immune activation, microbial trans-location, and the HIV DNA level in HIV/HCV-coinfected patients. J. Infect. Dis., 218 (4), 624–632.10.1093/infdis/jiy13629986086Search in Google Scholar

Macias, J., Japon, M. A., Saez, C., Palacios, R. B., Mira, J. A., Garcia-Garcia, J. A., Merchante, N., Vergara, S., Lozano, F., Gomez-Mateos, J., Pineda, J. A. (2005). Increased hepatocyte Fas expression and apoptosis in HIV and hepatitis C virus infection. J. Infect. Dis., 192, 1566–1576.10.1086/49173616206071Search in Google Scholar

Marchetti, G., Bellistri, G. M., Borghi, E., Tincati, C., Ferramosca, S., La Francesca, M., Morace, G., Gori, A., d`Arminio Monforte, A. (2008). Microbial translocation is associated with sustained failure in CD+ T-cell reconstitution in HIV-infected patients on long-term highly active anti-retroviral therapy. AIDS, 22, 2035–2044.10.1097/QAD.0b013e3283112d2918784466Search in Google Scholar

Marchetti, G., Cozzi-Lepri, A., Merlini, E., Bellistri, G. M., Castagna, A., Galli, M., Verrucchi, G., Antinori, A., Costantini, A., Giacometti, A., di Caro, A., D’arminio Monforte, A. (2011). Microbial translocation predicts disease progression of HIV- infected antiretroviral- naïve patients with high CD4+ cell count. AIDS, 25, 1385–1394.10.1097/QAD.0b013e3283471d1021505312Search in Google Scholar

Marchetti, G., Tincati, C., Silvestri, G. (2013). Microbial translocation in the pathogenesis of HIV infection and AIDS. Clin. Microbiol. Rev., 26, 2–18.10.1128/CMR.00050-12355366823297256Search in Google Scholar

Marquez, M., Romero-Cores, P., Montes-Oca, M., Martin-Aspas, A., Soto-Cardenas, M.-J., Guerrero, F., Fernandez-Gutierrez, C., Giron-Gonzalez, J.-A. (2015). Immune activation response in chronic HIV-infected patients: Influence of hepatitis C virus coinfection. PLoS ONE, 10 (3), 1–15.10.1371/journal.pone.0119568436159725775475Search in Google Scholar

Marks, M. A., Rabkin, C. S., Engels, E. A., Busch, E., Kopp, W., Rager, H., Goedert, J. J., Chaturvedi, A. K. (2012). Markers of microbial translocation and risk of AIDS-related lymphoma. AIDS, 27, 469–474.10.1097/QAD.0b013e32835c133323169327Search in Google Scholar

Mhawej, M.-J., Brunet-Francois, C., Fonteneau, R., Ernst, D., Ferre, V., Stan, G.-B., Raffi, F., Moog, C. H. (2009). Apoptosis characterizes immunological failure of HIV infected patients. Control Eng. Practice, 17, 798–804.10.1016/j.conengprac.2009.01.001Search in Google Scholar

Nien, H.-C., Hsu, S.-J., Su, T.-H., Yang, P.-J., Sheu, J.-C., Wang, J.-T., Chow, L.-P., Chen, C.-L., Kao, J.-H., Yang, W.-S. (2017). High serum lipopolysaccharide-binding protein level in chronic hepatitis C viral infection is reduced by anti-viral treatments. PLoS ONE, 12 (1), 1–11.10.1371/journal.pone.0170028524920628107471Search in Google Scholar

Novati, S., Sacchi, P., Cima, S., Zuccaro, V., Columpsi, P., Pagani, L., Filice, G., Bruno, R. (2015). General issues on microbial translocation in HIV-infected patients. Eur. Rev. Med. Pharmacol. Sci,, 19, 866–878.Search in Google Scholar

de Oliveira Pinto, L. M., Lecoeur, H., Ledru, E., Rapp, C., Patey, O., Gougeon, M.-L. (2002). Lack of control of T cell apoptosis under HAART. Influence of therapy regimen in vivo and in vitro. AIDS, 16, 329–339.10.1097/00002030-200202150-0000311834943Search in Google Scholar

Parfieniuk-Kowerda, A., Lapinski T. W., Rogalska-Plonska, M., Swiderska, M., Panasiuk, A., Jaroszewicz, J., Flisika, R. (2013). Serum cytochrome c and m30-neoepitope of cytokeratin-18 in chronic hepatitis C. Liver Int., 34, 544–550.10.1111/liv.1229723981197Search in Google Scholar

Roger, P.-M., Breittmayer, J.-P., Durant, J., Sanderson, F., Ceppi, C., Brignone, C., Cua, E., Clevenbergh, P., Fuzibet, J.-G., Pesce, A., Bernard, A., Dellamonica, P. (2002). Early CD4+ T cell recovery in human immunodeficiency virus-infected patients receiving effective therapy is related to a down-regulation of apoptosis and not to proliferation. J. Infect. Dis.,185, 463–470.10.1086/33857311865398Search in Google Scholar

Rohrbach, J., Stickel, F., Schmid, P., Thormann, W., Kovari, H., Scherrer, A., Gunthard, H. F., Vuichard, D., Cavassini, M., Ambrosioni, J., Bernasconi, E., Furrer, H., Rauch, A. (2013). Changes in biomarkers of liver disease during successful combination antiretroviral therapy in HIV-HCV-coinfected individuals. Antiviral Ther., 19, 149–159.10.3851/IMP268624036684Search in Google Scholar

Sandler, N. G., Wand, H., Roque, A., Law, M., Nason, M. C., Nixon, D. E., Pedersen, C., Ruxrungtham, K., Lewin, S. R., Emery, S., Neaton, J. D., Brenchley, J. M., Deeks, S. G., Sereti, I., Douek, D. C. (2011). Plasma levels of soluble CD14 independently predict mortality in HIV patients. J. Infect. Dis.,203, 780–790.10.1093/infdis/jiq118307112721252259Search in Google Scholar

Sandler, N. G., Douek, D. C. (2012). Microbial translocation in HIV infection: Causes, consequences and treatment opportunities. Nature Rev. Microbiol., 10, 655–666.10.1038/nrmicro284822886237Search in Google Scholar

Seidel, N., Volkmann, X., Langer, F., Flemming, P., Manns, M. P., Schulze-Osthoff, K., Bantel, H. (2005). The extent of liver steatosis in chronic hepatitis C virus infection is mirrored by caspase activity in serum. Hepatology, 42, 113–120.10.1002/hep.2074715920717Search in Google Scholar

Vassallo, M., Mercie, P., Cottalorda, J., Ticchioni, M., Dellamonica, P. (2012). The role of lipopolysaccharide as a marker of immune activation in HIV-1 infected patients: A systematic literature review. Virology J., 9 (174), 1–8.10.1186/1743-422X-9-174349584822925532Search in Google Scholar